Cargando…
When genetic burden reaches threshold
Rare cardiac genetic diseases have generally been considered to be broadly Mendelian in nature, with clinical genetic testing for these conditions predicated on the detection of a primary causative rare pathogenic variant that will enable cascade genetic screening in families. However, substantial v...
Autores principales: | Walsh, Roddy, Tadros, Rafik, Bezzina, Connie R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599032/ https://www.ncbi.nlm.nih.gov/pubmed/32350504 http://dx.doi.org/10.1093/eurheartj/ehaa269 |
Ejemplares similares
-
Illuminating the path from genetics to clinical outcome in Brugada syndrome
por: Postema, Pieter G, et al.
Publicado: (2021) -
“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?
por: Eichler, H‐G, et al.
Publicado: (2016) -
Heart failure following STEMI: a contemporary cohort study of incidence and prognostic factors
por: Gho, Johannes M I H, et al.
Publicado: (2017) -
Cardiac papillary fibroelastoma; when, how, why?
por: Baikoussis, Nikolaos G., et al.
Publicado: (2016) -
Hypertension in Women: Should There be a Sex-specific Threshold?
por: Gerdts, Eva, et al.
Publicado: (2021)